RPID

Company Overview — What Does RAPID MICRO BIOSYSTEMS, INC. Do?

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts. RAPID MICRO BIOSYSTEMS, INC. (RPID) is classified as a micro-cap stock in the Technology sector, specifically within the Measuring And Control Equipment industry. The company is led by CEO Robert Spignesi and employs approximately 200 people. With a market capitalization of $98M, RPID is one of the notable companies in the Technology sector.

RAPID MICRO BIOSYSTEMS, INC. (RPID) Stock Rating — Avoid (April 2026)

As of April 2026, RAPID MICRO BIOSYSTEMS, INC. receives a Avoid rating with a composite score of 28.6/100 and 1 out of 5 stars from the Blank Capital Research quantitative model.RPID ranks #4,179 out of 4,446 stocks in our coverage universe. Within the Technology sector, RAPID MICRO BIOSYSTEMS, INC. ranks #539 of 584 stocks, placing it in the lower half of its Technology peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

RPID Stock Price and 52-Week Range

RAPID MICRO BIOSYSTEMS, INC. (RPID) currently trades at $2.15. The stock gained $0.03 (1.3%) in the most recent trading session. The 52-week high for RPID is $4.94, which means the stock is currently trading -56.5% from its annual peak. The 52-week low is $1.86, putting the stock 15.5% above its annual trough. Recent trading volume was 154K shares, suggesting relatively thin trading activity.

Is RPID Overvalued or Undervalued? — Valuation Analysis

RAPID MICRO BIOSYSTEMS, INC. (RPID) carries a value factor score of 14/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 2.97x, versus the sector average of 3.16x. The price-to-sales ratio is 3.30x, compared to 1.06x for the average Technology stock.

At current multiples, RAPID MICRO BIOSYSTEMS, INC. trades at a premium to most Technology peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

RAPID MICRO BIOSYSTEMS, INC. Profitability — ROE, Margins, and Quality Score

RAPID MICRO BIOSYSTEMS, INC. (RPID) earns a quality factor score of 19/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -138.4%, compared to the Technology sector average of -1.4%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -61.4% versus the sector average of -1.0%.

On a margin basis, RAPID MICRO BIOSYSTEMS, INC. reports gross margins of 9.0%, compared to 50.9% for the sector. The operating margin is -158.1% (sector: -0.5%). Net profit margin stands at -153.8%, versus -1.5% for the average Technology stock. Revenue growth is running at 18.4% on a trailing basis, compared to 14.2% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

RPID Debt, Balance Sheet, and Financial Health

RAPID MICRO BIOSYSTEMS, INC. has a debt-to-equity ratio of 125.0%, compared to the Technology sector average of 43.0%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. The current ratio is 3.31x, indicating strong short-term liquidity. Total debt on the balance sheet is $23M. Cash and equivalents stand at $19M.

RPID has a beta of 1.47, meaning it is more volatile than the broader market — a $10,000 investment in RPID would be expected to move 46.5% more than the S&P 500 on any given day. The stability factor score for RAPID MICRO BIOSYSTEMS, INC. is 22/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

RAPID MICRO BIOSYSTEMS, INC. Revenue and Earnings History — Quarterly Trend

In TTM 2026, RAPID MICRO BIOSYSTEMS, INC. reported revenue of $30M and earnings per share (EPS) of $-1.05. Net income for the quarter was $-46M. Gross margin was 9.0%. Operating income came in at $-47M.

In FY 2025, RAPID MICRO BIOSYSTEMS, INC. reported revenue of $34M and earnings per share (EPS) of $-1.05. Net income for the quarter was $-47M. Revenue grew 19.7% year-over-year compared to FY 2024. Operating income came in at $-47M.

In Q3 2025, RAPID MICRO BIOSYSTEMS, INC. reported revenue of $8M and earnings per share (EPS) of $-0.26. Net income for the quarter was $-12M. Revenue grew 3.1% year-over-year compared to Q3 2024. Operating income came in at $-11M.

In Q2 2025, RAPID MICRO BIOSYSTEMS, INC. reported revenue of $7M and earnings per share (EPS) of $-0.27. Net income for the quarter was $-12M. Revenue grew 9.7% year-over-year compared to Q2 2024. Operating income came in at $-12M.

Over the past 8 quarters, RAPID MICRO BIOSYSTEMS, INC. has demonstrated a growth trajectory, with revenue expanding from $7M to $30M. Investors analyzing RPID stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

RPID Dividend Yield and Income Analysis

RAPID MICRO BIOSYSTEMS, INC. (RPID) does not currently pay a dividend. This is common among smaller companies in the Measuring And Control Equipment industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Technology dividend stocks may want to explore other Technology stocks or use the stock screener to filter by dividend yield.

RPID Momentum and Technical Analysis Profile

RAPID MICRO BIOSYSTEMS, INC. (RPID) has a momentum factor score of 45/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 26/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 48/100 reflects moderate short selling activity.

RPID vs Competitors — Technology Sector Ranking and Peer Comparison

Within the Technology sector, RAPID MICRO BIOSYSTEMS, INC. (RPID) ranks #539 out of 584 stocks based on the Blank Capital composite score. This places RPID in the lower half of all Technology stocks in our coverage universe. Key competitors and sector peers include IHS Holding Ltd (IHS) with a score of 55.0/100, VERISIGN INC/CA (VRSN) with a score of 56.0/100, ESCO TECHNOLOGIES INC (ESE) with a score of 51.7/100, CareCloud, Inc. (CCLD) with a score of 46.9/100, and MMTec, Inc. (MTC) with a score of 47.4/100.

Comparing RPID against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full RPID vs S&P 500 (SPY) comparison to assess how RAPID MICRO BIOSYSTEMS, INC. stacks up against the broader market across all factor dimensions.

RPID Next Earnings Date

No upcoming earnings date has been announced for RAPID MICRO BIOSYSTEMS, INC. (RPID) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy RPID? — Investment Thesis Summary

The quantitative profile for RAPID MICRO BIOSYSTEMS, INC. suggests caution. The quality score of 19/100 flags below-average profitability. The value score of 14/100 indicates premium valuation. High volatility (stability score 22/100) increases portfolio risk.

In summary, RAPID MICRO BIOSYSTEMS, INC. (RPID) earns a Avoid rating with a composite score of 28.6/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on RPID stock.

Related Resources for RPID Investors

Explore more research and tools: RPID vs S&P 500 comparison, top Technology stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare RPID head-to-head with peers: RPID vs IHS, RPID vs VRSN, RPID vs ESE.